APA (7th ed.) Citation

Zhou, Q., Liang, J., Yang, T., Liu, J., Li, B., Li, Y., . . . Chen, L. (2022). Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO molecular medicine, 14(1), e14502-n/a. https://doi.org/10.15252/emmm.202114502

Chicago Style (17th ed.) Citation

Zhou, Qian, et al. "Carfilzomib Modulates Tumor Microenvironment to Potentiate Immune Checkpoint Therapy for Cancer." EMBO Molecular Medicine 14, no. 1 (2022): e14502-n/a. https://doi.org/10.15252/emmm.202114502.

MLA (9th ed.) Citation

Zhou, Qian, et al. "Carfilzomib Modulates Tumor Microenvironment to Potentiate Immune Checkpoint Therapy for Cancer." EMBO Molecular Medicine, vol. 14, no. 1, 2022, pp. e14502-n/a, https://doi.org/10.15252/emmm.202114502.